Stratifying risk in oligoprogressive EGFR-mutated non-small cell lung cancer (NSCLC): The role of liquid biopsy. Guijosa A, Rios-Garcia E, Davila-Dupont D, Cruz-Rico G, et al. Lung Cancer 2025;207:108722.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guijosa A, Rios-Garcia E, Davila-Dupont D, Cruz-Rico G, et al. Stratifying risk in oligoprogressive EGFR-mutated non-small cell lung cancer (NSCLC): The role of liquid biopsy. Lung Cancer 2025;207:108722.
PMID: 40857845